NCT03670927Befejeződött
Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults
Etiosarc: Study of the Environmental Aetiology (Environment, Occupations and Lifestyle) of Sarcomas (Soft Tissue, Visceral and Bone) From a Multicenter French Population-based Case-control Study Among Adults.
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2024. nov. 7.
Rövid összefoglaló (regiszter, angolul)
Introduction: Sarcomas are rare tumors of connective tissue. The exact overall incidence of sarcomas is unknown due to diagnostic difficulties and the various histological subtypes (over 80 subtypes). However, the apparent increasing incidence of sarcomas suggests environmental causes such as pesticides. Except for some specific factors (i.e. ionizing radiation, vinyl chloride, dioxin, and genetic predispositions) the scientific knowledge on the aetiology of sarcomas is sparse and inconsistent. France is a particularly appropriate country to set up a study investigating the causes of sarcoma occurrence due to the French organization in treatment and care of sarcoma patients, which is highly structured and revolved around national expert networks. The main objective of the ETIOSARC project is to study the role of lifestyle, environmental and occupational factors in the occurrence of sarcomas among adults from a multicentric population-based case-control study. Methods and analysis: Cases will be all incident cases (older than 18 years old) identified in 15 districts of France covered by a cancer registry and/or a reference center in sarcoma's patient care over a three-year period with an inclusion start date ranging from the 1st October 2018 to the 1st January 2020 and histologically confirmed by a second review of the diagnosis. Two controls will be individually-matched by sex, age (5-years group), and districts of residence and randomly selected from electoral list. A standardized questionnaire will be administered by a trained interviewer in order to gather information about occupational and residential history, demographic and socioeconomic characteristics and lifestyle factors. At the end of the interview, a saliva sample will be systematically proposed. This study will permit to validate or not already suspected risk factors for sarcomas such as phenoxyherbicides, chlorophenol and to generate new hypothesis to increase our understanding about the genetic and environmental contributions in the carcinogenicity process.
- Állapot (regiszter)
- Befejeződött
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 2237 (tényleges)
- Első benyújtás
- 2018. szept. 12.
- Kezdés
- 2019. ápr. 25.
- Elsődleges befejezés
- 2024. júl. 3.
- Fő szponzor
- Institut National de la Santé Et de la Recherche Médicale, France
- Betegségek
- Szarkóma
- NCT-szám
- NCT03670927
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Bevont résztvevők: 2237
- 2019. ápr. 25. és az elsődleges befejezés (2024. júl. 3.) között
- 10 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Controls
- Subject previously diagnosed with a primary and histologically confirmed malignant sarcoma including soft-tissue, visceral and bone sarcomas as defined by the WHO classification of bones and soft tissue sarcoma, fourth edition, 2013;
- Protected adults' patients (aged of at least 18 years old) under guardianship by court order.
Életkor
- Cases
- Patients with a known genetic predisposition to sarcoma such as Li-Fraumeni syndrome, Retinoblastoma syndrome, neurofibromatosis;
- Kaposi's' sarcoma;
- Protected adults' patients (aged of at least 18 years old) under guardianship by court order.
Kiket keres a vizsgálat
- Cases
- Patients diagnosed in the previous 6 months from identification with a primary and histologically confirmed malignant sarcoma including soft-tissue, visceral and bone sarcomas as defined by the WHO classification of bones and soft tissue sarcoma, fourth edition, 2013;
- Diagnosed over a three-year period with an inclusion start date ranging from the 1st October 2018 to the 1st January 2020;
- Living in the 15 districts participating to the study at the time of diagnosis
- French nationality (due to control selection within electoral lists);
- At least 18 years old at diagnosis;
- Agreed to participate to the study with a signed informed consent;
- Controls
- Subjects registered within the electoral rolls;
- At least 18 years old at interview;
- Living in the 15 districts participating to the study at the time of interview;
- Agreed to participate to the study with a signed informed consent;
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad
Helyszínek (10)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| CHRU | Besançon | Franciaország | Ismeretlen állapot |
| Institut Bergonie | Bordeaux | Franciaország | Ismeretlen állapot |
| Centre François Baclesse | Caen | Franciaország | Ismeretlen állapot |
| Centre Oscar Lambret | Lille | Franciaország | Ismeretlen állapot |
| Chu Dupuytren | Limoges | Franciaország | Ismeretlen állapot |
| Centre Leon Berard | Lyon | Franciaország | Ismeretlen állapot |
| Institut Régional du Cancer Montpellier | Montpellier | Franciaország | Ismeretlen állapot |
| CHU | Nantes | Franciaország | Ismeretlen állapot |
| CHRU | Strasbourg | Franciaország | Ismeretlen állapot |
| Institut Gustave Roussy | Villejuif | Franciaország | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.